Fig. 3

Serial changes in SDF-1α levels and the EPC/HPC ratio in the RIJV in14 cell-treated patients A ELISA findings for identification of the time courses of stromal cell-derived factor (SDF)-1α in cell-treated patients; analytical result of SDF-1α, * vs. other groups with different symbols (†, ‡, §, ¶), p < 0.0001. B Flow cytometric analysis of the levels of CD34 + KDR + CD45^dim cells at baseline and over time; analytical result of the number of CD34 + KDR + CD45^dim cells; * vs. other groups with different symbols (†, ‡, §), p < 0.0001. C Flow cytometric analysis of the levels CD34 + CD133 + CD45^dim cells at baseline and over time; analytical result of the number of CD34 + CD133 + CD45^dim cells; * vs. other groups with different symbols (†, ‡, §), p < 0.0001. D Flow cytometric analysis of CD34 + CD133 + KDR + cells at baseline and over time; analytical result of the number of CD34 + CD133 + KDR + cells; * vs. other groups with different symbols (†, ‡), p < 0.0001. E Flow cytometric analysis of CD31 + CD133 + CD45^dim cells at baseline and over time; analytical results of the number of CD31 + CD133 + CD45^dim cells; * vs. other groups with different symbols (†, ‡, §, ¶, α), p < 0.0001. F Flow cytometric analysis of CD34 + cells and the analytical results of the number of CD34 + cells at baseline and over time; * vs. other groups with different symbols (†, ‡, §), p < 0.0001. G Flow cytometric analysis of CD133 + cells and the analytical results of the number of CD133 + cells at baseline and over time; * vs. other groups with different symbols (†, ‡, §), p < 0.0001. All the statistical analyses were performed using one-way ANOVA, followed by the Bonferroni multiple comparison post hoc test (n = 14 for each group). Symbols (*, †, ‡) indicate significance (at the 0.05 level). G-CSF = granulocyte-colony stimulating factor; RIJV = right internal jugular vein; EPCs = endothelial progenitor cells